Voyager Therapeutics (VYGR)
(Delayed Data from NSDQ)
$7.74 USD
-0.24 (-3.01%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $7.74 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Brokerage Reports
0 items in cart
Voyager Therapeutics, Inc. [VYGR]
Reports for Purchase
Showing records 1 - 20 ( 140 total )
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Tracking Tau -- Looking Ahead To Clinical Advancement
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Raise When You Can -- VYGR Announces Secondary Offering
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
New NVS Agreement Generates More Non-Dilutive Capital To Start Year
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Optimized Entry and Exit Levels for VYGR 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Tau Efforts Continue To Tick Closer To Clinic; All Efforts On Track
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
All Cylinders Firing With SOD1 Candidate Selection Nearing
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
With Another Inbound Milestone, 4Q22 Results Largely As Anticipated
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Gimme That GBA1 - VYGR, NBIX Announce Collaborative Parkinson''s Deal
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Putting A Stake In The Ground - Pipeline Prioritization Efforts
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Making It Official - VYGR Appoints Al Sandrock To CEO Role
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Additional TRACER Licensing Deal Extends Cash Runway
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
CFO Dorval To Depart, Still Awaiting More Clarity on Path Forward
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L